Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates.
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.
Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.
Advances in Antioxidative Therapy of Multiple Sclerosis.
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
HMGB1 in Development and Diseases of the Central Nervous System.
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
Imaging of microglia in patients with neurodegenerative disorders.
Self-reported health promotion and disability progression in multiple sclerosis.
Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.
Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
Torque teno mini virus infection and multiple sclerosis.
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.
Pages
« first
‹ previous
…
213
214
215
216
217
218
219
220
221
…
next ›
last »